Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Pretreatment with Anti-CD3 Monoclonal Antibody Depletes Recipient CCR7 + Dendritic Cells and Prevents Graft-Versus-Host Disease While Preserving GVL Effects,

Can Liu, MD, Wei He, MD, Xiaofan Li, MD, Heather F Johnston, Miao Wang, MD, Jeremy Racine, Paul J Martin, MD, Stephen Forman, MD, Defu Zeng, MD

Blood (2011) 118 (21): 4024.

https://doi.org/10.1182/blood.V118.21.4024.4024

Published: 2011

Journal Articles

Tissue Parenchymal Cell Expression of B7-H1 Inhibits Infiltrating T Cell Expansion and Prevents Persistence of Graft-Versus-Host Disease

Xiaofan Li, MD, Wei He, MD, Ruishu Deng, MD, Can Liu, MD, Miao Wang, MD, James Young, Lieping Chen, MD, PhD, Yuan-Zhong Chen, MD, Paul J Martin, MD, Stephen Forman, MD, Defu Zeng, MD

Blood (2011) 118 (21): 2974.

https://doi.org/10.1182/blood.V118.21.2974.2974

Published: 2011

Journal Articles

An Engineered Cell Surface Polypeptide for Selection, Tracking and Ablation of Genetically Modified Hematopoietically Derived Cells Based on Human EGFR.

Xiuli Wang, MD, PhD, Wen-Chung Chang, MS, ChingLam W Wong, BS, David Colcher, PhD, Mark Sherman, PhD, Julie R Ostberg, PhD, Stanley R. Riddell, MD, Stephen Forman, MD, Michael C Jensen, MD

Blood (2010) 116 (21): 1469.

https://doi.org/10.1182/blood.V116.21.1469.1469

Published: 2010

Journal Articles

Extramedullary Relapse Following Reduced Intensity AlloHCT for Adult AML.

Neil Martin Kogut, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS, Joyce Collins, PhD, Margaret O'Donnell, M.D., F.R.C.P.C., Anthony Selwyn Stein, M.D., Ricardo Spielberger, MD, Stephen Forman, MD

Blood (2010) 116 (21): 3467.

https://doi.org/10.1182/blood.V116.21.3467.3467

Published: 2010

Journal Articles

Final Report of a Phase I Study of Clofarabine Plus High Dose Melphalan as a Conditioning Regimen for Allogeneic Transplantation

Mark Kirschbaum, MD, Anthony Selwyn Stein, M.D., Paul Frankel, Leslie Popplewell, M.D., Robert w Chen, Maria L Delioukina, MD, Ryotaro Nakamura, MD, David S. Snyder, MD, Cynthia Slape, Christopher Ruel, Joel Conrad, Auayporn Nademanee, M.D., Stephen Forman, MD

Blood (2010) 116 (21): 528.

https://doi.org/10.1182/blood.V116.21.528.528

Published: 2010

Journal Articles

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Plus Rituximab in Newly Diagnosed, Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Mark Kirschbaum, MD, Leslie Popplewell, M.D., Maria L Delioukina, MD, Robert w Chen, Vinod Pullarkat, Paul Frankel, Joel Conrad, Joyce Hartshorn, Auayporn Nademanee, M.D., Stephen Forman, MD

Blood (2010) 116 (21): 3957.

https://doi.org/10.1182/blood.V116.21.3957.3957

Published: 2010

Journal Articles

Aprepitant (Emend®) Significantly Increases Sirolimus Levels In Patients Undergoing Allogeneic Hematopoietic Stem Cell transplantation.

Sepideh Shayani, Pharm.D., Joycelynne Palmer, PhD, Tracey Stiller, Chan Holly, Pharm. D., Svetlana Keuylian, Pharm.D., Pablo Miguel Parker, M.D., Stephen Forman, MD, Ryotaro Nakamura, MD

Blood (2010) 116 (21): 1311.

https://doi.org/10.1182/blood.V116.21.1311.1311

Published: 2010

Journal Articles

Engraftment Fitness of Human Central Memory-Derived Effector CD8 + T Cells In Immunodeficient Mice

Xiuli Wang, MD, PhD, Berger Carolina, PhD, Stanley R. Riddell, MD, ChingLam W Wong, BS, Stephen Forman, MD, Michael C Jensen, MD

Blood (2010) 116 (21): 1019.

https://doi.org/10.1182/blood.V116.21.1019.1019

Published: 2010

Journal Articles

Synergistic Effect of Anti-CD3 and Vorinostat in the Prevention of Acute Gvhd and Retention of GVL in a Radiation-Free Conditioning Regimen.

Wei He, PhD, MD, Mark Kirschbaum, MD, Nainong Li, PhD, MD, Tangsheng Yi, PhD, Hong-Jun Liu, Stephen Forman, MD, Defu Zeng, MD

Blood (2009) 114 (22): 3562.

https://doi.org/10.1182/blood.V114.22.3562.3562

Published: 2009

Journal Articles

Truncation in CCND1 mRNA 3′ UTR Is Associated with An Aggressive Phenotype and Chemoresistance

Robert W Chen, MD, Myo Htut, MD, Britta Hoehn, PhD, Eamon Berge, MD, William Robinson, MD, PhD, John Rossi, PhD, Stephen Forman, MD, Lynne Bemis, PhD

Blood (2008) 112 (11): 5287.

https://doi.org/10.1182/blood.V112.11.5287.5287

Published: 2008

Journal Articles

Histone Deacetylase Inhibitor SAHA Reduces Cytokine Storm and Facilitates Induction of Chimerism When Combined with Anti-CD3 mAb in Conditioning of Recipients.

Nainong Li, MD/PhD, Dongchang Zhao, MD/PhD, Chunyan Zhang, MD/PhD, Chia-Lei Lin, Mark Kirschbaum, MD, Fouad Kandeel, MD, Stephen Forman, MD, Defu Zeng, MD

Blood (2007) 110 (11): 2168.

https://doi.org/10.1182/blood.V110.11.2168.2168

Published: 2007

Journal Articles

Updated Results of High-Dose Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan with High-Dose Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Autologous Hematopoietic Cell Transplant (AHSCT) for Poor-Risk or Refractory B-Cell Non-Hodgkin’s Lymphoma.

Auayporn Nademanee, MD, Andrew Raubitschek, MD, Arturo Molina, MD, Joycelynne Palmer, Ph.D, Ni-Chun Tsai, MS, Amrita Krishnan, MD, Neil Kogut, MD, Stephen Forman, MD

Blood (2007) 110 (11): 1891.

https://doi.org/10.1182/blood.V110.11.1891.1891

Published: 2007

Journal Articles

Augmenting the Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) by Addition of Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy in Patients (pts) with Advanced Hematological Malignancies.

Joseph Rosenthal, MD, Jeffrey Wong, MD, Anthony Stein, MD, Ellen Bolotin, MD, PhD, Chatchada Karanes, MD, Leslie Popplwell, MD, Auayporn Nademanee, MD, Firoozeh Sahebi, MD, Margaret O’Donnell, MD, Maria Delioukina, MD, George Somlo, MD, Anna Pawlowska, MD, Debbie Hitt, RN, Marianna Shakhnovits, MD, Stephen Forman, MD

Blood (2007) 110 (11): 3021.

https://doi.org/10.1182/blood.V110.11.3021.3021

Published: 2007

Journal Articles

Non-Myeloablative Conditioning Regimen (NMCR) for Allogeneic Bone Marrow Transplantation (BMT) in Patients with Severe Aplastic Anemia (SAA).

Joseph Rosenthal, MD, Anna Pawlowska, MD, Ellen Bolotin, MD, PhD, Peter Falk, MD, Cheryl Oliver, RN, Stephen Forman, MD

Blood (2007) 110 (11): 4943.

https://doi.org/10.1182/blood.V110.11.4943.4943

Published: 2007

Journal Articles

In Vivo Activated CD103 + CD4 + Regulatory T Cells Ameliorate Ongoing Chronic GVHD.

Dongchang Zhao, MD, PhD, Chunyan Zhang, MD/PhD, Tangsheng Yi, Chia-Lei Lin, Ivan Todorov, PhD, Fouad Kandeel, MD, Stephen Forman, MD, Defu Zeng, MD

Blood (2007) 110 (11): 350.

https://doi.org/10.1182/blood.V110.11.350.350

Published: 2007

Journal Articles

Fludarabine, Cyclophosphamide and ATG Based, Reduced Intensity Conditioning for HLA-Match Sibling Donor Transplant in Severe Aplasic Anemia (SAA) - Case Report.

Anna B. Pawlowska, MD, Ellen Bolotin, MD, Peter Falk, MD, Stephen Forman, MD, Joseph Rosenthal, MD

Blood (2006) 108 (11): 5370.

https://doi.org/10.1182/blood.V108.11.5370.5370

Published: 2006

Journal Articles

Low Risk of Relapse in Pediatric Patients after Double Unit Cord Blood Transplantation.

Joseph Rosenthal, MD, Ellen Bolotin, MD, Anna B. Pawlowska, MD, Peter Falk, MD, Stephen Forman, MD

Blood (2006) 108 (11): 5416.

https://doi.org/10.1182/blood.V108.11.5416.5416

Published: 2006

Journal Articles

Donor CD8 + T Cells Mediate GVL without GVHD in Recipients Conditioned with Anti-CD3 mAb.

Chunyan Zhang, MD, PhD, Jingwei Lou, MD, PhD, Naninong Li, MD, PhD, Ivan Todorov, PhD, Chia-Lei Lin, BS, Yu-An Cao, MD, PhD, Christopher H. Contag, PhD, Fouad Kandeel, MD, PhD, Stephen Forman, MD, Defu Zeng, MD

Blood (2006) 108 (11): 192.

https://doi.org/10.1182/blood.V108.11.192.192

Published: 2006

Journal Articles

A Radiation-Free Immune and Epigenetics Based Conditioning Regimen for Allogeneic HCT: Combination of Anti-CD3 and Romidepsin.

Nainong Li, MD, PhD, Chunyan Zhang, MD, PhD, Chia-Lei Lin, BS, Bill McCulloch, MD, John Wright, MD, Mark Kirschbaum, MD, Stephen Forman, MD, Defu Zeng, MD

Blood (2006) 108 (11): 3204.

https://doi.org/10.1182/blood.V108.11.3204.3204

Published: 2006

Journal Articles

Phase II Randomized Trial of Bevacizumab Versus Bevacizumab and Thalidomide for Relapsed/Refractory Multiple Myeloma.

George Somlo, MD, William Bellamy, PhD, Todd M. Zimmerman, MD, Paul Frankel, PhD, Joe Tuscano, MD, Margaret O’Donnell, MD, Ann Mohrbacher, MD, Stephen Forman, MD, Helen Chen, MD, James Doroshow, MD, David Gandara, MD

Blood (2005) 106 (11): 2571.

https://doi.org/10.1182/blood.V106.11.2571.2571

Published: 2005

NARROW

Pretreatment with Anti-CD3 Monoclonal Antibody Depletes Recipient CCR7 + Dendritic Cells and Prevents Graft-Versus-Host Disease While Preserving GVL Effects,

Tissue Parenchymal Cell Expression of B7-H1 Inhibits Infiltrating T Cell Expansion and Prevents Persistence of Graft-Versus-Host Disease

An Engineered Cell Surface Polypeptide for Selection, Tracking and Ablation of Genetically Modified Hematopoietically Derived Cells Based on Human EGFR.

Extramedullary Relapse Following Reduced Intensity AlloHCT for Adult AML.

Final Report of a Phase I Study of Clofarabine Plus High Dose Melphalan as a Conditioning Regimen for Allogeneic Transplantation

A Phase 2 Study of Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Plus Rituximab in Newly Diagnosed, Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma

Aprepitant (Emend®) Significantly Increases Sirolimus Levels In Patients Undergoing Allogeneic Hematopoietic Stem Cell transplantation.

Engraftment Fitness of Human Central Memory-Derived Effector CD8 + T Cells In Immunodeficient Mice

Synergistic Effect of Anti-CD3 and Vorinostat in the Prevention of Acute Gvhd and Retention of GVL in a Radiation-Free Conditioning Regimen.

Truncation in CCND1 mRNA 3′ UTR Is Associated with An Aggressive Phenotype and Chemoresistance

Histone Deacetylase Inhibitor SAHA Reduces Cytokine Storm and Facilitates Induction of Chimerism When Combined with Anti-CD3 mAb in Conditioning of Recipients.

Updated Results of High-Dose Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan with High-Dose Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Autologous Hematopoietic Cell Transplant (AHSCT) for Poor-Risk or Refractory B-Cell Non-Hodgkin’s Lymphoma.

Augmenting the Reduced Intensity Conditioning (RIC) Regimen of Fludarabine (FLU) and Melphalan (MEL) by Addition of Total Marrow and Lymph Node Irradiation (TMLI) Using Helical Tomotherapy in Patients (pts) with Advanced Hematological Malignancies.

Non-Myeloablative Conditioning Regimen (NMCR) for Allogeneic Bone Marrow Transplantation (BMT) in Patients with Severe Aplastic Anemia (SAA).

In Vivo Activated CD103 + CD4 + Regulatory T Cells Ameliorate Ongoing Chronic GVHD.

Fludarabine, Cyclophosphamide and ATG Based, Reduced Intensity Conditioning for HLA-Match Sibling Donor Transplant in Severe Aplasic Anemia (SAA) - Case Report.

Low Risk of Relapse in Pediatric Patients after Double Unit Cord Blood Transplantation.

Donor CD8 + T Cells Mediate GVL without GVHD in Recipients Conditioned with Anti-CD3 mAb.

A Radiation-Free Immune and Epigenetics Based Conditioning Regimen for Allogeneic HCT: Combination of Anti-CD3 and Romidepsin.

Phase II Randomized Trial of Bevacizumab Versus Bevacizumab and Thalidomide for Relapsed/Refractory Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only